tiprankstipranks

Chris Rallis Insider Profile

4 Followers
Chris Rallis, Director at Fennec Pharmaceuticals, holds 45.84K shares in Fennec Pharmaceuticals (Ticker: FENC), holds ― shares in Tenax Therapeutics (Ticker: TENX). Most recently, Chris Rallis Sold ― shares of Fennec Pharmaceuticals on Apr 15, 2024 for an estimated value of 8.36K.
tipranks
Chris Rallis

Chris Rallis
Fennec Pharmaceuticals (FENC)
Director

Ranked #21,434 out of 99,541 Corporate Insiders

Profitable Transactions

44%
7 out of 16 Profitable Transactions

Average Return

+4.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$310K
100.00%
0.00%
A breakdown of Chris Rallis's holdings

Insider Roles

Fennec Pharmaceuticals
(FENC)
Director
Tenax Therapeutics
(TENX)
Director
Roles that Chris Rallis holds in companies

Most Profitable Insider Trade

Stock:
Fennec Pharmaceuticals
(FENC)
Rating:Informative Buy
Date:Mar 08, 2022 - Mar 08, 2023
Return:+75.00%
The most profitable trade made by Chris Rallis

Chris Rallis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fennec Pharmaceuticals
Apr 15, 2024
Director
Informative Sell
8.36K
$309.86K
Tenax Therapeutics
Aug 22, 2016
Director
Informative Buy
25.00K
List of latest transactions for each holding click on a transaction to see Chris Rallis's performance on stock

Chris Rallis insider profile FAQ

What is the percentage of profitable transactions made by Chris Rallis?
The percentage of profitable transactions made by Chris Rallis is 44%.
    What is the average return per transaction made by Chris Rallis?
    The average return per transaction made by Chris Rallis is 4.60%.
      What stocks does Chris Rallis hold?
      Chris Rallis holds: FENC, TENX stocks.
        What was Chris Rallis’s latest transaction?
        Chris Rallis latest transaction was an Informative Sell of $8.36K.
          What was Chris Rallis's most profitable transaction?
          Chris Rallis’s most profitable transaction was an Informative Buy of FENC stock on March 8, 2022. The return on the trade was 75.00%.
            What is Chris Rallis's role in Fennec Pharmaceuticals?
            Chris Rallis's role in Fennec Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.